Defining Keratin Protein Function in Skin Epithelia: Epidermolysis Bullosa Simplex and Its Aftermath

被引:97
作者
Coulombe, Pierre A. [1 ,2 ,3 ]
Lee, Chang-Hun [1 ]
机构
[1] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Dermatol, Sch Med, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
INTERMEDIATE-FILAMENT PROTEINS; STRATIFIED SQUAMOUS EPITHELIA; TRIMETHYLAMINE N-OXIDE; EPIDERMAL KERATIN; MOTTLED PIGMENTATION; DOWLING-MEARA; GENETIC-BASIS; PRENATAL-DIAGNOSIS; MUSCULAR-DYSTROPHY; STRESS-RESPONSE;
D O I
10.1038/jid.2011.450
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
Epidermolysis bullosa simplex (EBS) is a rare genetic condition typified by superficial bullous lesions following incident frictional trauma to the skin. Most cases of EBS are due to dominantly acting mutations in keratin 14 (K14) or K5, the type I and II intermediate filament (IF) proteins that copolymerize to form a pancytoplasmic network of 10nm filaments in basal keratinocytes of epidermis and related epithelia. Defects in K5-K14 filament network architecture cause basal keratinocytes to become fragile, and account for their rupture upon exposure to mechanical trauma. The discovery of the etiology and pathophysiology of EBS was intimately linked to the quest for an understanding of the properties and function of keratin filaments in skin epithelia. Since then, continued cross-fertilization between basic science efforts and clinical endeavors has highlighted several additional functional roles for keratin proteins in the skin, suggested new avenues for effective therapies for keratin-based diseases, and expanded our understanding of the remarkable properties of the skin as an organ system.
引用
收藏
页码:763 / 775
页数:13
相关论文
共 144 条
[1]
THE EXPRESSION OF MUTANT EPIDERMAL KERATIN CDNAS TRANSFECTED IN SIMPLE EPITHELIAL AND SQUAMOUS-CELL CARCINOMA LINES [J].
ALBERS, K ;
FUCHS, E .
JOURNAL OF CELL BIOLOGY, 1987, 105 (02) :791-806
[2]
EXPRESSION OF MUTANT KERATIN CDNAS IN EPITHELIAL-CELLS REVEALS POSSIBLE MECHANISMS FOR INITIATION AND ASSEMBLY OF INTERMEDIATE FILAMENTS [J].
ALBERS, K ;
FUCHS, E .
JOURNAL OF CELL BIOLOGY, 1989, 108 (04) :1477-1493
[4]
Development of Allele-Specific Therapeutic siRNA for Keratin 5 Mutations in Epidermolysis Bullosa Simplex [J].
Atkinson, Sarah D. ;
McGilligan, Victoria E. ;
Liao, Haihui ;
Szeverenyi, Ildiko ;
Smith, Frances J. D. ;
Moore, C. B. Tara ;
McLean, W. H. Irwin .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (10) :2079-2086
[5]
Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells [J].
Beil, M ;
Micoulet, A ;
von Wichert, G ;
Paschke, S ;
Walther, P ;
Omary, MB ;
Van Veldhoven, PP ;
Gern, U ;
Wolff-Hieber, E ;
Eggermann, J ;
Waltenberger, J ;
Adler, G ;
Spatz, J ;
Seufferlein, T .
NATURE CELL BIOLOGY, 2003, 5 (09) :803-811
[6]
Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease [J].
Betz, RC ;
Planko, L ;
Eigelshoven, S ;
Hanneken, S ;
Pasternack, SM ;
Büssow, H ;
Van den Bogaert, K ;
Wenzel, J ;
Braun-Falco, M ;
Rütten, A ;
Rogers, MA ;
Ruzicka, T ;
Nöthen, MM ;
Magin, TM ;
Kruse, R .
AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 78 (03) :510-519
[7]
EPIDERMOLYSIS-BULLOSA SIMPLEX - EVIDENCE IN 2 FAMILIES FOR KERATIN GENE ABNORMALITIES [J].
BONIFAS, JM ;
ROTHMAN, AL ;
EPSTEIN, EH .
SCIENCE, 1991, 254 (5035) :1202-1205
[8]
BYRNE C, 1994, DEVELOPMENT, V120, P2369
[9]
An inducible mouse model for epidermolysis bullosa simplex: Implications for gene therapy [J].
Cao, TY ;
Longley, MA ;
Wang, XJ ;
Roop, DR .
JOURNAL OF CELL BIOLOGY, 2001, 152 (03) :651-656
[10]
Epidermolysis bullosa simplex due to KRT5 mutations: mutation-related differences in cellular fragility and the protective effects of trimethylamine N-oxide in cultured primary keratinocytes [J].
Chamcheu, J. C. ;
Virtanen, M. ;
Navsaria, H. ;
Bowden, P. E. ;
Vahlquist, A. ;
Torma, H. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (05) :980-989